1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33721
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2023-09-01T07:06:28Z-
dc.date.available2023-09-01T07:06:28Z-
dc.date.issued2017-
dc.identifier.citationErer, S. ve Zarifoğlu, M. (2017). ''Improvements in non-motor and motor fluctuations in Parkinson's disease after intermittent apomorphine treatment''. Neurology India, 65(2), 388-U361.en_US
dc.identifier.issn0028-3886-
dc.identifier.issn1998-4022-
dc.identifier.urihttps://doi.org/10.4103/neuroindia.NI_437_15-
dc.identifier.urihttp://hdl.handle.net/11452/33721-
dc.language.isoenen_US
dc.publisherWolters Kuwer Medknow Publicationsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.subject.meshAgeden_US
dc.subject.meshApomorphineen_US
dc.subject.meshDopamine agentsen_US
dc.subject.meshHumansen_US
dc.subject.meshParkinson diseaseen_US
dc.titleImprovements in non-motor and motor fluctuations in Parkinson's disease after intermittent apomorphine treatmenten_US
dc.typeLetteren_US
dc.identifier.wos000398598400032tr_TR
dc.identifier.scopus2-s2.0-85015616859tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı/Parkinson Hastalığı ve Hareket Bozuklukları Anabilim Dalı.tr_TR
dc.identifier.startpage388tr_TR
dc.identifier.endpageU361tr_TR
dc.identifier.volume65tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalNeurology Indiaen_US
dc.contributor.buuauthorErer, Sevda-
dc.contributor.buuauthorZarifoğlu, Mehmet-
dc.identifier.pubmed28290407tr_TR
dc.subject.wosNeurosciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubMeden_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid25635370800tr_TR
dc.contributor.scopusid6603411305tr_TR
dc.subject.emtreeAgeden_US
dc.subject.emtreeAkinesiaen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeDrug dose reductionen_US
dc.subject.emtreeDrug intermittent therapyen_US
dc.subject.emtreeDiseaseen_US
dc.subject.emtreeRemissionen_US
dc.subject.emtreeSalt intakeen_US
dc.subject.emtreeSubstitution therapyen_US
dc.subject.emtreeTreatment planningen_US
dc.subject.emtreeTremoren_US
dc.subject.emtreeUnified parkinson disease rating scaleen_US
dc.subject.emtreeParkinson diseaseen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreeDopamine receptor stimulating agenten_US
dc.subject.emtreeApomorphineen_US
dc.subject.emtreeBenserazide plus levodopaen_US
dc.subject.emtreeCarbidopa plus entacapone plus levodopaen_US
dc.subject.emtreeRasagilineen_US
dc.subject.emtreeRopiniroleen_US
dc.subject.emtreeApomorphineen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.